QuidelOrtho Declares that its Molecular Diagnostics Approach will be Refocused
QuidelOrtho Corporation (NASDAQ:QDEL) has announced a strategic pivot in its molecular diagnostics business, seeking to acquire full ownership of LEX Diagnostics following projected 510(k) FDA clearance...